ViroMed
1996
FOUNDED
PUBLIC
STATUS
101-200
EMPLOYEES
084990
STOCK SYMBOL
1
INVESTMENTS
$84.65
SHARE PRICE
(As of Friday Closing)
Description
Helixmith Co Ltd, formerly ViroMed Co Ltd is active in the healthcare sector in Korea. The company specializes in developing pharmaceutical products for the treatment of diseases related to peripheral artery, coronary artery, cardiovascular system and neuropathy, cancer and allergy. Its suite of products includes protein/deoxyribonucleic acid (DNA)-based biopharmaceuticals, botanical drugs and natural pharmaceuticals.
Website
Formerly Known As
ViroMedica Pacific
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
KRX
Primary Office
- 5th Floor, Building 203, SNU
- No. 599 Gwanak-ro, Gwanak-gu
- Seoul, 151-747
- South Korea
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore ViroMed’s full profile, request a free trial.
ViroMed Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $53.49 - $220.64 | $1.8B | $83.78 | -$1.20 | 1.34M | 21.3M |
ViroMed Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 2,370,008 | 3,591,715 | 2,431,078 | 1,220,264 |
| Revenue | 4,549 | 4,805 | 2,785 | 5,874 |
| EBITDA | (24,162) | (27,713) | (6,821) | (512) |
| Net Income | (24,384) | (26,138) | (5,728) | (613) |
| Total Assets | 261,321 | 254,166 | 167,867 | 147,325 |
| Total Debt | 101,085 | 73,212 | 10,657 | 3,860 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
ViroMed Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore ViroMed‘s full profile, request access.
Request full access to PitchBookViroMed Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 (000 0000000 | 20-Aug-2018 | 000000000 00000 00 | Buildings and Property | 00000000 000 00.0 |
ViroMed Executive Team (4)
ViroMed Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Jong-Mook Kim Ph.D | ViroMed | Co-Founder, Director, Development Division & Strategic Business Division & Board Member | 000 0000 | |
| Sungchul Kim | ViroMed | Co-Founder, Board Member, Chief Financial Officer & Director, Management Support Division | 000 0000 |